CNX IT, CNX Pharma index down 2%

Infosys, TCS, Tech Mahindra, Wipro, HCL Tech, Aurobindo, Cipla, Dr Reddy's, Sun Pharma and Ranbaxy down 1-4% on NSE

SI Reporter Mumbai
Last Updated : Oct 08 2014 | 10:28 AM IST
Shares of information technology (IT) and pharmaceutical companies are under pressure, falling by upto 3% after the International Monetary Fund (IMF) cut its outlook for global growth.

Infosys, Tata Consultancy Services (TCS), Tech Mahindra, Wipro and HCL Technologies from IT and Aurobindo Pharma, Cipla, Dr Reddy’s Laboratories, Sun Pharma Industries, Ranbaxy Laboratories and Lupin from healthcare are down 1-4%.

The National Stock Exchange CNX IT (down 2.5%) and CNX Pharma (down 1.7%) are the largest losers among sector indices down nearly 2% each compared to a marginal 0.10% fall in CNX Nifty at 1020 hours.

Meanwhile, CNX Pharma (up 19%) and CNX IT (13%) had outperformed the market in past three months against just 1% rise in benchmark index till yesterday.

According to Reuters report, the MF cut its global economic growth forecasts for the third time this year, suggesting the environment remains difficult for companies, especially ones with multinational exposure.

Among the IT pack, Tech Mahindra and Hexaware Technologies were down 4% each, while Infosys, Wipro, TCS and HCL Technologies were down 2-3% on NSE.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 08 2014 | 10:18 AM IST

Next Story